Paediatric Oncology Literature

Thursday, 13 September 2012

AML02


Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, Pounds S, Razzouk BI, Lacayo NJ, Cao X, Meshinchi S, Degar B, Airewele G, Raimondi SC, Onciu M,Coustan-Smith E, Downing JR, Leung W, Pui CH, Campana D. Minimal residualdisease-directed therapy for childhood acute myeloid leukaemia: results of theAML02 multicentre trial. Lancet Oncol. 2010 Jun;11(6):543-52. 
Posted by Ramandeep Arora at 01:47
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: Leukaemia, MRD, Randomised Controlled Trial

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Labels

abandonment (3) Bone tumours (3) central america (1) Chemotherapy (3) Clinical Trial (1) CNS Tumours (4) COG (3) delayed diagnosis (2) England (5) Epidemiology (10) Febrile Neutropenia (2) GCT (1) Genetics (1) Guidelines (5) Histiocytosis (1) Hodgkin Disease (2) Incidence (6) India (12) Leukaemia (5) Medulloblastoma (1) mortality (3) MRD (2) Non-Hodgkin's Lymphoma (1) PHO IAP (1) PODC (2) Radiology (1) Radiotherapy (3) Raman (3) Randomised Controlled Trial (5) relapse (1) Report (2) retinoblastoma (1) Review (1) SIOP (3) soft tissue sarcoma (1) south america (1) Supportive Care (2) Trends (1) TYA (3) UK (1) Wilms Tumour (1)

Blog Archive

  • ►  2013 (4)
    • ►  April (2)
    • ►  February (1)
    • ►  January (1)
  • ▼  2012 (26)
    • ►  December (1)
    • ►  November (2)
    • ►  October (3)
    • ▼  September (20)
      • Outcome after abandonment
      • Delayed diagnosis brazil
      • Childhood cancer trends
      • Febrile Neutropenia Guidelines
      • PHO IAP Brain Tumours Report
      • Childhood Brain Tumours Vellore
      • Childhood Brain Tumours India from Multiple Centres
      • Sarcoma abandonment
      • ALL Relapse India
      • AML02
      • Cancer Incidence Delhi
      • Childhood Mortality India
      • Cancer Mortality India
      • TYA Bone tumours England
      • GCT England Incidence
      • India England TYA Incidence
      • Sikkim Cancer Indicence
      • ALL India Genetics
      • Standard Risk Medulloblastoma and Radiotherapy
      • Hodgkin Disease and Radiotherapy

About Me

My photo
Ramandeep Arora
I have done my initial paediatric training in India and then went to UK for further training in paediatric oncology and cancer epidemiology. Having spent 11 years there I moved back to India in 2013 and have joined Max Healthcare, New Delhi as a consultant paediatric oncologist. My main area of interest is childhood cancer with a specific focus on paediatric oncology in developing countries and childhood cancer epidemiology. I am also interested in understanding the phenomenon of refusal and abandonment in treatment of childhood cancer in developing countries and to develop interventions to deal with it.
View my complete profile
Simple theme. Powered by Blogger.